1999
DOI: 10.1016/s0090-6980(99)90421-5
|View full text |Cite
|
Sign up to set email alerts
|

Aspirin-triggered 15-epi-lipoxin A4 (ATL) generation by human leukocytes and murine peritonitis exudates: Development of a specific 15-epi-LXA4 ELISA

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

5
86
0

Year Published

2000
2000
2014
2014

Publication Types

Select...
7
1

Relationship

4
4

Authors

Journals

citations
Cited by 62 publications
(91 citation statements)
references
References 0 publications
5
86
0
Order By: Relevance
“…In vivo, topical application of methyl esters of LXs and their stable analogs as well as the ATLs proved to be very effective for delivery. These methyl esters are converted to the corresponding free acids that are very likely in view of the present results to be responsible for the in vivo gene expression regulation and leukocyte trafficking impact (17)(18)(19).…”
Section: Discussionmentioning
confidence: 76%
“…In vivo, topical application of methyl esters of LXs and their stable analogs as well as the ATLs proved to be very effective for delivery. These methyl esters are converted to the corresponding free acids that are very likely in view of the present results to be responsible for the in vivo gene expression regulation and leukocyte trafficking impact (17)(18)(19).…”
Section: Discussionmentioning
confidence: 76%
“…For example, ATL is generated in vivo from AA in healthy human subjects taking low-dose aspirin (33). As demonstrated in acute inflammation models (34,35), ATL is at least partially responsible for anti-neutrophilic and subsequent antiinflammatory, pro-resolving actions in humans of low-dose (75-81 mg) aspirin (29,33). These anti-neutrophilic recruitment and pro-resolving doses are significantly lower than the classical and generally used anti-rheumatic and anti-inflammatory doses (325-650 mg range) (36).…”
Section: Figurementioning
confidence: 99%
“…Examples are ions m/z 277 from RvD1 ( Figure 1 and Scheme 3), 261 from PD1 ( Figure 2, Scheme 4), 245 from 17-HpDHA (Figure 4 and Scheme 6), 195 from LTB 4 and 251 from LXA 4 [27,29], as well as ions 285 from 20-HDHA, 245 from 17-HDHA, 205 from 14-HDHA, and 165 from 11-HDHA (Table 1, Supplemental Figure 1 and Scheme 5). These fragmentation processes can also occur through ␥-ene-rearrangement if the cc segment has a ␥ double bond, which is at least the second double bond counted from the carboxyl group (for ion-trap MS/MS, unnecessary for triplequadrupole MS/MS, such as for 8 cc of 8,9-dihydroxyeicosatrienoic acids [27], and an ␣ allylic single bond [27,29].…”
Section: [Cc ϩ H] Ions In Ms/ms Of Lipid Mediatorsmentioning
confidence: 99%
“…This process also takes place through ␥-ene-rearrangement if the segment mm has a ␥-double bond and an ␣ allylic single bond. Examples are ions 141 from RvD1 ( Figure 1, Scheme 3), 193 from 11-HDHA, and 153 from 8-HDHA (Table 1, Supplemental Figure 1 and Scheme 5), as well as ions 145 of 5,6-diHETrE, 185 of 8,9-diHETrE, and 115 of both 5,6-diHETE and LXA 4 [27,29,30]. [mc Ϫ H] ions are also produced through an ␣-H-␤-ene rearrangement with shift of the ␣-H from segment mc to the ␥ position in segment mm whose ␣-bond is a vinyl single bond and ␤-bond is a double bond, such as ions m/z 261 from 16-HDHA (Table 1 (Table 1, Supplemental Figure 1 and Scheme 5), which are generated through a ␥-ene rearrangement and an ␣-H-␤-ene rearrangement, respectively.…”
Section: [Mc ϫ H] Ions In Ms/ms Of Lipid Mediatorsmentioning
confidence: 99%